{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:36:48Z","timestamp":1767854208131,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biosystems"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.biosystems.2013.04.003","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T03:52:59Z","timestamp":1368071579000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists"],"prefix":"10.1016","volume":"115","author":[{"given":"Lihui","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Tianjun","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jinan","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Guohui","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Yonghua","family":"Wang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biosystems.2013.04.003_bib0005","first-page":"771","article-title":"Adenosine A2A receptor antagonists as novel anti-Parkinsonian agents: a review of structure\u2013activity relationships","volume":"64","author":"Azam","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0010","first-page":"366","article-title":"[19] Integrated methods for the construction of three-dimensional models and computational probing of structure\u2013function relations in G protein-coupled receptors","volume":"vol. 25","author":"Ballesteros","year":"1995"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000073136.00548.D4","article-title":"Adenosine A(2A) receptor antagonist treatment of Parkinson's disease","volume":"61","author":"Bara-Jimenez","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0020","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1021\/j100308a038","article-title":"The missing term in effective pair potentials","volume":"91","author":"Berendsen","year":"1987","journal-title":"The Journal of Physical Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-540-89615-9_8","article-title":"Adenosine receptors and inflammation","volume":"193","author":"Blackburn","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"1","key":"10.1016\/j.biosystems.2013.04.003_bib0030","doi-asserted-by":"crossref","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"The Journal of Physical Chemistry"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0035","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/jm100240h","article-title":"Structure-based discovery of A2A adenosine receptor ligands","volume":"53","author":"Carlsson","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0040","series-title":"AMBER 10","author":"Case","year":"2008"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/480652","article-title":"Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure\u2013activity relationships","author":"Cheong","year":"2011","journal-title":"International Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/j.biosystems.2013.04.003_bib0050","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","article-title":"Validation of the general purpose tripos 5.2 force field","volume":"10","author":"Clark","year":"1989","journal-title":"Journal of Computational Chemistry"},{"issue":"5","key":"10.1016\/j.biosystems.2013.04.003_bib0055","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm201376w","article-title":"Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design","volume":"55","author":"Congreve","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"15","key":"10.1016\/j.biosystems.2013.04.003_bib0060","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2174\/138161208784480081","article-title":"A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure\u2013activity relationship analysis and binding requirements of agonists and antagonists","volume":"14","author":"Cristalli","year":"2008","journal-title":"Current Pharmaceutical Design"},{"issue":"11","key":"10.1016\/j.biosystems.2013.04.003_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1145\/240455.240477","article-title":"LogP: a practical model of parallel computation","volume":"39","author":"Culler","year":"1996","journal-title":"Communications of the ACM"},{"issue":"12","key":"10.1016\/j.biosystems.2013.04.003_bib0070","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald \u2013 an N.Log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"Journal of Chemical Physics"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0075","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.str.2011.06.014","article-title":"Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine","volume":"19","author":"Dore","year":"2011","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.biosystems.2013.04.003_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ardp.201000124","article-title":"Antiparkinsonian effects of novel adenosine A(2A) receptor antagonists","volume":"344","author":"Drabczynska","year":"2011","journal-title":"Archiv der Pharmazie"},{"issue":"2","key":"10.1016\/j.biosystems.2013.04.003_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(96)00944-2","article-title":"Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats","volume":"321","author":"Fenu","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/978-3-540-89615-9_14","article-title":"Adenosine receptors and cancer","volume":"193","author":"Fishman","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.20833","article-title":"Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease","volume":"65","author":"Frau","year":"2011","journal-title":"Synapse"},{"issue":"22","key":"10.1016\/j.biosystems.2013.04.003_bib0100","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0105","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bmcl.2008.03.075","article-title":"Antagonists of the human adenosine A2A receptor. Part 1. Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives","volume":"18","author":"Gillespie","year":"2008","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0110","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.bmcl.2008.03.076","article-title":"Antagonists of the human adenosine A2A receptor. Part 2. Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives","volume":"18","author":"Gillespie","year":"2008","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0115","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.bmcl.2008.03.072","article-title":"Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines","volume":"18","author":"Gillespie","year":"2008","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.biosystems.2013.04.003_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/jm800961g","article-title":"Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines","volume":"52","author":"Gillespie","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"issue":"18","key":"10.1016\/j.biosystems.2013.04.003_bib0125","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1016\/j.bmc.2009.07.078","article-title":"Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides","volume":"17","author":"Gillespie","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.biosystems.2013.04.003_bib0130","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.bmcl.2009.03.142","article-title":"Antagonists of the human A(2A) receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides","volume":"19","author":"Gillespie","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.biosystems.2013.04.003_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/jm800961g","article-title":"Antagonists of the Human A(2A) Adenosine Receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines","volume":"52","author":"Gillespie","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-540-89615-9_7","article-title":"Adenosine receptors and reperfusion injury of the heart","volume":"193","author":"Headrick","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"6860","key":"10.1016\/j.biosystems.2013.04.003_bib0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/35102535","article-title":"Water conduction through the hydrophobic channel of a carbon nanotube","volume":"414","author":"Hummer","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biosystems.2013.04.003_bib0155","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jmgm.2006.06.004","article-title":"Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors","volume":"25","author":"Ivanov","year":"2007","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"10","key":"10.1016\/j.biosystems.2013.04.003_bib0160","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/jm801533x","article-title":"Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure","volume":"52","author":"Ivanov","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5905","key":"10.1016\/j.biosystems.2013.04.003_bib0165","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.1164772","article-title":"The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist","volume":"322","author":"Jaakola","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.096974","article-title":"Identification and characterization of amino acid residues essential for human A2A adenosine receptor: ZM241385 binding and subtype selectivity","author":"Jaakola","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.biosystems.2013.04.003_bib0175","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","article-title":"Adenosine, adenosine A 2A antagonists, and Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/j.biosystems.2013.04.003_bib0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410430415","article-title":"Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys","volume":"43","author":"Kanda","year":"1998","journal-title":"Annals of Neurology"},{"issue":"11 (Suppl. 6)","key":"10.1016\/j.biosystems.2013.04.003_bib0185","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1212\/01.WNL.0000095219.22086.31","article-title":"Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease","volume":"61","author":"Kase","year":"2003","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.biosystems.2013.04.003_bib0190","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1074\/jbc.270.23.13987","article-title":"Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor","volume":"270","author":"Kim","year":"1995","journal-title":"Journal of Biological Chemistry"},{"issue":"23","key":"10.1016\/j.biosystems.2013.04.003_bib0195","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1021\/jm0300431","article-title":"Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists","volume":"46","author":"Kim","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.biosystems.2013.04.003_bib0200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/10799893.2012.660532","article-title":"Pharmacophore mapping and in silico screening to identify new potent leads for A2A adenosine receptor, as antagonists","volume":"32","author":"Kiran","year":"2012","journal-title":"Journal of Receptors and Signal Transduction"},{"issue":"5","key":"10.1016\/j.biosystems.2013.04.003_bib0205","first-page":"668","article-title":"KW-6002 (Kyowa Hakko Kogyo)","volume":"2","author":"Knutsen","year":"2001","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"5","key":"10.1016\/j.biosystems.2013.04.003_bib0210","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1021\/jm201455y","article-title":"Identification of novel adenosine A(2A) receptor antagonists by virtual screening","volume":"55","author":"Langmead","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/j.biosystems.2013.04.003_bib0215","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00044-010-9431-1","article-title":"Prediction of the binding affinities of adenosine A2A receptor antagonists based on the heuristic method and support vector machine","volume":"20","author":"Lu","year":"2011","journal-title":"Medicinal Chemistry Research"},{"issue":"2","key":"10.1016\/j.biosystems.2013.04.003_bib0220","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ci700300w","article-title":"Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor","volume":"48","author":"Michielan","year":"2008","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"4","key":"10.1016\/j.biosystems.2013.04.003_bib0225","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bmcl.2008.01.036","article-title":"2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability","volume":"18","author":"Moorjani","year":"2008","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0230","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-3-540-89615-9_18","article-title":"Adenosine A2A receptors and Parkinson's disease","volume":"193","author":"Morelli","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"4","key":"10.1016\/j.biosystems.2013.04.003_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00124499","article-title":"Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4","volume":"10","author":"Morris","year":"1996","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"14","key":"10.1016\/j.biosystems.2013.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.chemolab.2011.03.011","article-title":"Further exploring rm2 metrics for validation of QSPR models","volume":"107","author":"Ojha","year":"2011","journal-title":"Chemometrics and Intelligent Laboratory Systems"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1997.tb48412.x","article-title":"Adenosine A2A receptors and neuroprotection","volume":"825","author":"Ongini","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/j.biosystems.2013.04.003_bib0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/prot.10028","article-title":"Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock","volume":"46","author":"Osterberg","year":"2002","journal-title":"Proteins"},{"issue":"12","key":"10.1016\/j.biosystems.2013.04.003_bib0260","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"A polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"Journal of Applied Physics"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0265","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0165-6147(97)01096-1","article-title":"Adenosine A(2A) receptor antagonists as new agents for the treatment of Parkinson's disease","volume":"18","author":"Richardson","year":"1997","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0270","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jcc.23231","article-title":"Some case studies on application of rm2 metrics for judging quality of QSAR predictions: emphasis on scaling of response data","volume":"34","author":"Roy","year":"2013","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/138955712800493861","article-title":"On the use of the metric rm2 as an effective tool for validation of QSAR models in computational drug design and predictive toxicology","volume":"12","author":"Roy","year":"2012","journal-title":"Mini-Reviews in Medicinal Chemistry"},{"key":"10.1016\/j.biosystems.2013.04.003_bib0280","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/ci200520g","article-title":"Comparative studies on some metrics for external validation of QSPR models","volume":"52","author":"Roy","year":"2012","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","article-title":"Reduced surface: an efficient way to compute molecular surfaces","volume":"38","author":"Sanner","year":"1966","journal-title":"Biopolymers"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0290","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"Journal of Molecular Biology"},{"issue":"3","key":"10.1016\/j.biosystems.2013.04.003_bib0295","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/jm9911480","article-title":"Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists","volume":"43","author":"Sauer","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"10.1016\/j.biosystems.2013.04.003_bib0300","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10.1016\/j.biosystems.2013.04.003_bib0305","first-page":"466","article-title":"Recent progress in the discovery of adenosine A(2A) receptor antagonists for the treatment of Parkinson's disease","volume":"13","author":"Shah","year":"2010","journal-title":"Current Opinion in Drug Discovery & Development"},{"issue":"9","key":"10.1016\/j.biosystems.2013.04.003_bib0310","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"Journal of Computational Chemistry"},{"issue":"25","key":"10.1016\/j.biosystems.2013.04.003_bib0315","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.2174\/092986710791859298","article-title":"Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics","volume":"17","author":"Wang","year":"2010","journal-title":"Current Medicinal Chemistry"},{"issue":"26","key":"10.1016\/j.biosystems.2013.04.003_bib0320","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.2174\/092986711796957220","article-title":"Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics","volume":"18","author":"Zhang","year":"2011","journal-title":"Current Medicinal Chemistry"}],"container-title":["Biosystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303264713000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303264713000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T11:48:15Z","timestamp":1563018495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303264713000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":64,"alternative-id":["S0303264713000907"],"URL":"https:\/\/doi.org\/10.1016\/j.biosystems.2013.04.003","relation":{},"ISSN":["0303-2647"],"issn-type":[{"value":"0303-2647","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"Biosystems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biosystems.2013.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}